Here's Earli co-founder and CEO Cyriac Roeding in a wide-ranging interview with Tough Tech Today podcast hosts Forrest Meyen and Jonathan Miller.
Cyriac discusses Earli’s origins in the laboratories at Stanford, why early detection is one of the most promising ways to reduce cancer deaths, and how Earli’s scientists managed to get their synthetic biopsy technology into a clinic faster than anyone thought was possible. Cyriac dives deep into the bioengineering behind Earli’s technology and makes a compelling case for why the future of early cancer detection looks brighter than ever.
Listen to the full episode on your favorite podcast platform or check out the video on YouTube.
